“CREATING VALUE BY HELPING PEOPLE”

AMG International GmbH (AMG), a Q3 Medical Limited Holding Company, is a German based developer, manufacturer, and seller of high-end Cardiology and Peripheral Vascular devices in Europe, South America, Middle East, and Asia. AMG was founded in 1997 as a manufacturer and distributor for implantable medical devices, with a focus on the global commercialization of its technology to reduce the total cost of care for patients globally. 

In 2017 AMG launched its AMG GI brand for the company’s new Biodegradable Non-Vascular product line. The ARCHIMEDES Biodegradable replacement for the 2 Million plastic stents used annually that require a 2nd surgery for removal and have complication rates as high as 30% is currently available for sale in the Europe. The UNITY-B Biodegradable Balloon Expandable Biliary Stent (Unity-B) which is focused on replacing the estimated 1 Billion Euro gastrointestinal metal stent market is now also available for sale in Europe. 

The AMG GI Biodegradable Solutions Platform is the first biodegradable system available to treat HPB disease and surgical complications.


Brochures:

amg ARCHIMEDES BPS

amg UNITY-B

ARCHIMEDES:

ERCP

IR

HBP

UNITY-B Endo

About Q3 Medical Devices Ltd.

Q3 Medical Devices Ltd. is an Ireland based holding company with multiple global operations in Germany, China, & the United States focused on “Creating Value By Helping People” through the development, manufacturing and distribution of its novel biodegradable and Micro Invasive
Technologies products platform for the interventional peripheral vascular and non-vascular markets. www.q3medical.com